There are four different versions of pancreatic cancers.
That's according to a team of researchers who recently examined how the cancer starts and spreads at the molecular level. They found there are actually four distinct types of the disease –– each with its own causes, survival rates and best course of treatment.
Current treatments for pancreatic cancer are a sort of one-size-fits-all approach, and most patients are diagnosed relatively late. Only 4 percent live five years or more after being diagnosed.
One of the study's authors said, "There are a number of different chemotherapeutic options, but in general it's not very selective — it's like hitting the disease with a mallet with your eyes closed."
Since the causes of cancer attack one's genetic blueprint, the researchers are now turning to genetic information from a large sample of patients with the four different types of pancreatic cancer.
They hope this will lead to patients being given "the right treatment at the right time," and further down the road, making that treatment personalized.